Nice, FRANCE - 17 Jun `19Glisodin with UVB

Official Title: Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo. A Randomized Double Blind Placebo Controlled Monocentric Study

In Brief: Glisodin 4 pills a day (1000mg) for 3 months then 2 pills a day (500 mg) for 3 months

Ages Eligible:  18 Years and older

Start Date: June 17, 2019

Completion Date (estimated): November 2, 2020

Status: Active, recruiting

Study ID from ClinicalTrials.gov: NCT03941808

Location: Centre Hospitalier Universitaire de Nice at Nice, Alpes-Maritime, France, 06001

Contact: To learn more about this study, you or your doctor may contact Passeron Thierry, PhD by phone +33492034688 or email passeron.t@chu-nice.fr. Please refer to this study by its NCT number.         

FAQOther Questions

  • What is vitiligo?

     Vitiligo (pronounced vit-ill-EYE-go) is a generally unpredictable skin disease that causes a gradual loss of skin color and overlying hair on different parts of the body. Cont...

  • What tests should be done?

    A well-trained dermatologist should be able to diagnose vitiligo and distinguish it from contact leukoderma or more than twenty other conditions with similar skin appearance bas...

  • Is vitiligo contagious?

    Vitiligo is NOT contagious. It cannot be passed on or caught from touching someone with vitiligo, shaking hands, swimming in the same pool, sharing towels, sitting next to someo...